Neodymium: VAG laser hysteroscopy in large submucous fibroids
|
|
- Magdalene Catherine Garrison
- 6 years ago
- Views:
Transcription
1 FERTILITY AND STERILITY Copyright <> 1990 The American Fertility Society Printed on acid-free paper in U.S.A. Neodymium: VAG laser hysteroscopy in large submucous fibroids Jacques Donnez, M.D., Ph.D.* Stephane Gillerot, M.D. Damieri Bourgonjon, M.D. Franc;:oise Clerckx, B.S. Michelle Nisolle, M.D. Infertility Research Unit, Department of Gynecology, University of Louvain, Brussels, Belgium The preoperative use of a potent, subcutaneously injected gonadotropin-releasing hormone agonist ( GnRH -a) was evaluated in a series of 60 women with large submucosal fibroids. Myomectomy by hysteroscopy and Nd:YAG laser was easily performed. In 12 cases, the largest portion of the myoma was not inside the uterine cavity and myomectomy was carried by a two-step hysteroscopy. In women who wished to become pregnant, a pregnancy rate of 66% was achieved. Advantages of preoperative use of a GnRH-a are (1) the significant decrease of the fibroid size, (2) a lower fluid absorption, and (3) the restoration of a normal hemoglobin concentration. Fertil Steril54:999, 1990 Submucous uterine fibroids are common benign solid tumors of the genital tract, that may produce menorrhagia and/or infertility. The effect of a potent agonist gonadotropin-releasing hormone agonist (GnRH-a) on the size of uterine leiomyomas has been previously described. 1-6 In women with uterine fibroid associated infertility, use of GnRH-a represented an adjunct for preoperative reduction of tumor size 2 5 and permitted the surgical treatment by hysteroscopy if the greatest diameter of the fibroma was inside the uterine cavity. 5 The purpose of the current study was to describe the technique used by the authors in cases of very large submucous fibroids. MATERIALS AND METHODS Sixty women aged 23 to 40 years (mean 34 years) with symptomatic submucous uterine fibroids were treated with a biodegradable GnRH-a (Zoladex Implant ICI; Cambridge, United Kingdom). The implant was injected subcutaneously at the end of the Received March 19, 1990; revised and accepted July 25, * Reprint requests: Jacques Donnez, M.D., Ph.D., Infertility Research Unit, Department of Gynecology, University of Louvain, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, B-1200 Brussels, Belgium. luteal phase to curtail the initial gonadotropin stimulation phase always associated with a rise in estrogen. One implant was systematically injected at weeks 0, 4, and 8. Blood samples were drawn the day of the first implant injection, 7 days after, and every 2 weeks until the recovery of menstruation. Samples were assayed by radioimmuassay (RIA) for concentrations of gonadotropins (luteinizing hormone [LH], follicle-stimulating hormone [FSH], and estradiol [E 2]). Endometrial biopsy, hysterography, and hysteroscopy were performed before treatment and at 8 weeks. The uterine cavity area and the fibroid area were calculated as previously described 5 on the hysterography images using the short-line "multipurpose test system" described by Weibel. 6 Care was taken to carry out the hysterosalpingography in a standard fashion and to compare images of hysterography at the same degree of uterine and tubal filling by contrast and with the same reference marks to the pelvic bones. In cases of very large fibroids, transabdominal and transvaginal echography were performed to evaluate the depth of the intramural portion of the fibroids. At 8 weeks, hysteroscopic myomectomy was carried out with the help of the neodymium Y AG (N d: Y AG) laser. A Sharplan 2100 apparatus (Sharplan; Donnez et al. Hysteroscopy in submucous fibroids 999
2 ' - A l l cases... Myomas> 10 cm2..., Myomas> 5 < 10 cm2... Myomas< 5 cm ± ± ±6.7~ 6.9 ± ± ± the treatment period, LH and FSH concentrations were significantly suppressed by 2 weeks of treatment. Recovery of ovarian secretion occurred, on average ±10 weeks after the last injection, as proved by the significant increase of E 2 secretion observed 10 weeks after the last implant injection (58± 32 pg/ml). Evaluation of Hormonal Therapy 2.5 ± ± ~------~ ~ Weeks of therapy 0 8 Figure 1 Submucosal fibroid areas as assessed by hysterosalpingography before and after an 8-week GnRH -a therapy: B, all cases; A, women with initial fibroid area > 10 cm2 (n = 17); C, women with initial fibroid area> 5 cm2 < 10 cm2 (n = 22); and D, women with initial fibroid area< 5 cm 2 (n = 21). Tel-Aviv, Israel) was used for generating the laser. A power output of 80 W was used. The instrument used in our series was the operative hysteroscope with a deflecting arm (Storz; Tuttlingen, West Germany). The technique that the senior author (J.D.) used to provide constant distention involved attaching one 300-mL plastic bag of glycine solution (Travenol; Baxter, Brussels, Belgium) to blood infusion tubing. The bag was then wrapped in a pressure infusion cuff similar to that used to infuse blood under pressure. The tubing was connected to the hysteroscope. In case of bleeding during the intervention, the pressure infusion was increased so that the intrauterine pressure was above the arterial pressure until the blood vessel provoking the bleeding was coagulated with the help of the Nd:YAG laser. At the end of the procedure, no intrauterine stent was placed in the uterine cavity. No hormonal therapy, such as estrogens and progesterone, was given. The operating time varied from 10 to 50 minutes (mean 24 ± 6 minutes). Blood loss was minimal. Indeed, when blood loss was controlled, the difference between preoperative and postoperative (2 days) hemoglobin concentration was never > 1 g/l. Analysis of data from hysterosalpingography before and after treatment was performed with the Wilcoxon's rank sum test for matched pairs and Student's t-test. All data are expressed as the mean± SD. All patients had a pretreatment uterine cavity area > 10 cm 2 In all patients, the uterine cavity area was decreased, with an average decrease of 36%. The area decreased significantly (P < 0.01) from the baseline area (14.5 ± 5.1 cm 2 ) to 9.2 ± 3.4 cm 2 by 8 weeks of therapy. Using the same method, the decrease of very large submucous fibroid area was also calculated. When more than one fibroid was present, only the largest was evaluated. In all cases except two, the fibroid area was decreased by an average of 38%. However, the response was variable, ranging from 4% to 90%. Fibroid area decreased significantly (P < 0.01) from the baseline area (7.5 ± 6.7 cm 2 ) to 4.6 ± 4.8 cm 2 by 8 weeks of therapy. Figure 1 shows the mean fibroid areas in patients with a pretreatment fibroid area < 5 cm 2 (2.5 ± 1.2 to 1.6 ± 1.0 cm 2 ) versus those with an area > 5 cm 2 to <10 cm 2 (6.9 ± 1.2 to 4.0 ± 1.7 cm 2 ) and those with an area> 10 cm 2 (15.4 ± 7.6 to 9.5 ± 6.4 cm 2 ). In all subgroups, a signifi- RESULTS After a well-known initial stimulation of E 2 secretion, GnRH -a administration resulted in a postmenopausal E 2 range (16 ± 11 pg/ml). Throughout 1000 Donnez et al. Hysteroscopy in submucous fibroids Figure 2 A, Technique used for submucosal fibroid of which the greatest diameter is inside the uterine cavity; B, technique used for submucosal fibroid of which the greatest diameter is in the uterine wall. Fertility and Sterility
3 cant decrease (P < 0.005) was noted. There was no significant difference between the different subgroups. In patients with menorrhagia complaints (n = 38) the initial hemoglobin measurement was 11.3 ± 0.9 mg/l. Significant increase (13.8 ± 0.8 g/100 ml) (P < 0.005) was observed by the end of the 8-week treatment period. Moreover, the endometrium is atrophic. The amount of fluid absorbed was significantly (P < 0.05) lower in patients preoperatively treated with a GnRH-a (330 ± 210 ml) than in patients without any hormonal therapy 7-9 (750 ± 340 ml). Side effects of GnRH-a treatment, including hot flushes (58/60) and vaginal dryness (34/60), appeared the second week of therapy but were well tolerated. Hysteroscopic Myomectomy Submucosal Fibroid of Which the Greatest Diameter Was Inside the Uterine Cavity All patients underwent myomectomy by hysteroscopy and Nd:YAG laser. In all cases (n = 48), the operation was easily performed. The myometrium overlying the myoma was less vascular and the "shrinkage" of the uterine cavity may have accounted for the relative ease of separating the myoma from the surrounding myometrium (Fig. 2). The myoma was left in the uterine cavity. No complications such as infection, bleeding, or uterine contractions occurred. Office hysteroscopy done with C0 2 and carried out 2 to 3 months after myomectomy confirmed the complete disappearance of the myoma, which was probably "ejected" during the first menstruation occurring after the procedure. Large Submucosal Fibroid of Which the Largest Portion Was Located in the Uterine Wall In cases of very large submucous fibroids of which the largest portion was not inside the uterine cavity but well inside the uterine wall (n = 12) (Fig. 3), a two-step operative hysteroscopy was proposed (Fig. 2B). After 8 weeks preoperative GnRH therapy, a partial myomectomy was carried out by resecting the protruded portion of the myoma. Thereafter, the laser fiber was directed as perpendicularly as possible to the remaining (intramural) fibroid portion and was introduced in the fibroid on a length of 5 to 10 mm. During the application of laser energy, the fiber was removed slowly so that the deeper areas were coagulated. The end point of fibroid coagulation with this technique was identi- fied by distinct "craters" with brown borders on all fibroid area. The depth of the intramural fibroid portion was well known by echographic examination performed the day before surgery. The aim of this procedure was to decrease the size of the remaining myoma by decreasing the vascularity. A GnRH-a therapy was given for another 8 weeks and the second-look hysteroscopy was then performed. In all cases, the myoma was found to protrude again inside the uterine cavity and appeared very white and without any apparent vessel on its surface (Fig. 3). Myomectomy was then carried out as described for myomas in which the largest portion was inside the uterine cavity. The shrinkage of the uterine cavity allowed the residual myoma portion to be easily separated from the surrounding myometrium and dissected off the myometrium. At the end of the procedure, the myoma was left in the uterine cavity. No concomitant lap a roscopy was carried out, but should be suggested as the safest approach in some cases. In all cases, hysterography and hysteroscopy, carried out 2 to 3 months after myomectomy, confirms the disappearance of the myoma. The uterine cavity was normal. Long-Term Results In all cases, myomectomy permits the restoration of normal flow. Among the 60 women, 24 desired to become pregnant and had no other fertility factors. Sixteen (66%) of them became pregnant during the first 8 months after the recovery of menstruation. No miscarriage or premature labor was observed in this series; one cesarean section was mandatory because of fetal distress. DISCUSSION Because most leiomyomata return to near pretreatment size within 4 months after cessation of GnRH -a therapy 2, these agents cannot be used as definitive medical therapy. Several reports have demonstrated reductions in uterine and fibroid volumes by 52% to 77% after 6 months of GnRH-a therapy, as assessed by ultrasound imaging In a recent study, 5 as documented by hysterography imaging, an average decrease of 35% in the uterine cavity area was found. The current study demonstrated reductions in fibroid volume by 38% after 8 weeks of GnRH-a therapy. However, the response was variable ranging from 4% to 90%. There was no difference in the Donnez et al. Hysteroscopy in submucous fibroids 1001
4 , Figure 3 Submucosal fibroid of which the greatest diameter is in the myometrium. A, B, hysterosalpingography after GnRH-a therapy; C, D, hysterosalpingography before the "second" myomectomy (Note the protrusion of the earlier intramural portion). extent of decrease according to the pretreatment fibroid area. A treatment duration of 8 weeks was adapted before hysteroscopic myomectomy. Indeed, in a previous study,5 10 a significant uterine shrinkage was observed at 8 weeks of therapy, and uterine cavity area at 12 weeks was not significantly different from that found after 8 weeks of therapy. In cases of submucosal uterine fibroids, hysteroscopic myomectomy was carried out if the greater diameter of leiomyoma, as assessed by hysterography, was inside the uterine cavity. Myomas were easily separated from the surrounding myometrium with the help of the Nd:YAG laser. The preoperative blood loss was minimal, possibly because of decreased vascularity of the myometrium, which was demonstrated by a significant reduction in the 1002 Donnez et al. Hysteroscopy in submucous fibroids uterine arterial blood flow (Doppler), after treatment with a GnRH -a In all cases, the myoma was left in the uterine cavity and there were no complications. Office hysteroscopy performed after the first postoperative menstruation confirmed the disappearance of the myoma. Probably after a necrosis phase, it was ejected with the menstrual blood. In cases of very large fibroids of which the largest diameter was not inside the uterine cavity, the myomectomy was carried out in two steps. During the first surgical procedure, the protruding portion was removed and the intramural portion was devascularized by introducing the laser fiber in the myoma, on a length of 5 to 10 mm, depending on the depth of the remaining intramural portion, which was evaluated by echography performed before surgery. Fertility and Sterility
5 A very interesting finding was that this intramural portion of the myoma became submucosal and protruded again inside the uterine cavity, possibly because of the GnRH-a-induced uterine shrinkage, which provokes the protrusion of the remaining portion. In all cases, the largest diameter of the remaining portion was inside the uterine cavity so that myomectomy was easily performed by separating it from the surrounding myometrium with the help ofthe Nd:YAG laser. As previously evaluated by Goldrath/ 2 a temperature< 50oC was measured 1 em below the endometrial surface when the laser beam was set at 55 W and directed for 5 seconds at the tissue over the thermocouples. There is no risk of damage to the bowel or the bladder by transmural Nd:YAG energy effect. Indeed, in all cases, the distance between the deepest portion of the myoma and the uterine serosa was evaluated by echography. The pelvic structures were protected from injury because the distance between the top of the fiber and the external surface of the uterus was never <1.5 em. There was no risk to push a laser fiber as much as 1 em into the remaining portion if the diameter of the fibroid was >3 to 4 em. The procedure was never done under laparoscopic control, but concomitant laparoscopy must be suggested as the safest approach because.of the potential risks of bowel injury by doing this blindly. Because of the cessation of uterine bleeding, preoperative therapy resulted in the restoration of a normal hemoglobin concentration, which makes possible donation of blood for later transfusion. The decreased risk of transfusion-acquired infections could be substantial. The hormonal endometrial status is one of the factors affecting fluid absorption, 7 8 which is also a function of uterine distention pressure, length of anesthesia time, and amount of open uterine bed that is developed during the procedure. The endometrium vascularization may account for liquid resorption. During the menstrual cycle, the endometrium is well developed and there is an important vascularization. This important vascularization was reduced by a preoperative GnRH -a therapy. The amount of fluid absorbea was lower if the endometrium was atrophic. By reducing the amount of fluid absorbed, the preoperative GnRH -a therapy reduced the risk of fluid overload and this represents another advantage. In women with uterine fibroid-associated infertility, a pregnancy rate of 66% was achieved. Hysteroscopic myomectomy seems thus to improve fertility without affecting the mode of delivery. In conclusion, use of GnRH-a represents an adjunct for preoperative reduction of tumor size so that surgical treatment by hysteroscopy is possible. Even when the largest diameter is in the myometrium, the two-step hysteroscopic therapy combined with a GnRH -a therapy represents an ideal management of large submucous myomas and decreases the chance of myomectomy by laparotomy, which is often accompanied by operative blood loss and postoperative adhesion formation. REFERENCES 1. Healy DL, Fraser HM, Lawson SL: Shrinkage of a uterine fibroid after subcutaneous infusion of a LH-RH agonist. Br MedJ 209:267, Maheux R, Guilloteau C, Lemay A, Bastide A, Fazekas ATA: Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: pilot study. Am J Obstet Gynecol 152: 1034, Friedman AJ, Barbieri RL, Doubilet PM, Fine C, Schiff I: A randomized, double-blind trial of a gonadotropin releasinghormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment ofleiomyomata uteri. Fertil Steril 49:404, Andreyko JL, Blumenfeld Z, Marschall LA, Monroe SE, Hricak H, Jaffe RB: Use of an agonistic analog of gonadotropin-releasing hormcne (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging. Am J Obstet Gynecol158:903, Donnez J, Schrurs B, Gillerot S, Sandow J, Clerckx F: Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography. Fertil Steri151:947, Weibel ER: Practical methods for biological morphometry. In Stereogical methods, Vol. 1, Edited by ER Weibel. Bern, Switzerland, Academic Press, 1979, p Van Boven M, Singelyn F, Donnez J, Gribomont BF: Dilutional hyponatremia associated with intrauterine endoscopic laser surgery. Anesthesiology 3:71, Donnez J: unpublished data 9. Van Boven M, Singelyn F, Gribomont B: Complications and precautions in operative hysteroscopic surgery. In Laser Operative Laparoscopy and Hysteroscopy, Edited by J, Donnez. Leuven, Nauwelaerts Printing, 1989 p Donnez J, Schrurs B, Clerckx F, Nisolle M: Les agonistes de Ia LH-RH: une alternative dans le traitement de Ia myomatose uterine. Contrac Fertil Sex 17:47, Matta WHM, Stabile I, Shaw RS, Campbell S: Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin. Fertil Steril49:1083, Goldrath MH: Hysteroscopic laser surgery. In Basic and Advanced Laser Surgery in Gynecology, Edited by MH Baggish. Norwalk, Appleton-Century-Crofts, 1985, p 357 Donnez et al. Hysteroscopy in submucous fibroids 1003
INTERVENTIONAL PROCEDURES PROGRAMME
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of laparoscopic laser myomectomy Introduction This overview has been prepared to assist
More informationFrequency of menses. Duration of menses 3 days to 7 days. Flow/amount of menses Average blood loss with menstruation is 60-80cc.
Frequency of menses 24 days (0.5%) to 35 days (0.9%) Age 25, 40% are between 25 and 28 days Age 25-35, 60% are between 25 and 28 days Teens and women over 40 s cycles may be longer apart Duration of menses
More informationLaparoscopic myolysis
Human Reproduction Update 2000, Vol. 6, No. 6 pp. 609±613 Ó European Society of Human Reproduction and Embrology Laparoscopic myolysis Jacques Donnez*, Jean Squif et, Roland Polet and Michelle Nisolle
More informationClinical predictors for buserelin acetate treatment of uterine fibroids: a prospective study of 40 women
FERTILITY AND STERILITY Copyright" 1990 The American Fertility Society Printed on ocid-free paper in U.S.A. Clinical predictors for buserelin acetate treatment of uterine fibroids: a prospective study
More informationMedical Management of Fibroids Esmya. Dr Paula Briggs Consultant in Sexual and Reproductive Health
Medical Management of Fibroids Esmya Dr Paula Briggs Consultant in Sexual and Reproductive Health Treatment options for Uterine Fibroids ESMYA Selective Uterine Artery Embolisation Fibroid ablation (hysteroscopic
More informationFibroid mapping. Haitham Hamoda MD FRCOG Consultant Gynaecologist, Subspecialist in Reproductive Medicine & Surgery King s College Hospital
Fibroid mapping Haitham Hamoda MD FRCOG Consultant Gynaecologist, Subspecialist in Reproductive Medicine & Surgery King s College Hospital Fibroids Common condition >70% of women by onset of menopause.
More informationPalm Beach Obstetrics & Gynecology, PA
Palm Beach Obstetrics & Gynecology, PA 4671 S. Congress Avenue, Lake Worth, FL 33461 561.434.0111 4631 N. Congress Avenue, Suite 102, West Palm Beach, FL 33407 Endometriosis The lining of the uterus is
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationManagement of Uterine Myomas
Management of Uterine Myomas Deidre D. Gunn, MD Assistant Professor Division of Reproductive Endocrinology & Infertility February 16, 2018 Disclosures I have no relevant financial relationships to disclose.
More informationSURGICAL PROBLEMS IN FERTILITY- FIBROIDS. Dr.Māris Arājs gyn-ob specialist Cell phone:
SURGICAL PROBLEMS IN FERTILITY- FIBROIDS Dr.Māris Arājs gyn-ob specialist maris@myclinicriga.lv Cell phone: +371 26556466 There is NO Industry Sponsorship and Financial Conflict of Interest for this presentation
More informationModern Management of Fibroids
Modern Management of Fibroids Mr Narendra Pisal The Portland Hospital Fibroids Very common 20-40% of all women Up to 80% of black women by 50y Most fibroids are asymptomatic 50% will have significant symptoms
More informationAulia Rahman, S. Ked Endang Sri Wahyuni, S. Ked Nova Faradilla, S. Ked
Authors : Aulia Rahman, S. Ked Endang Sri Wahyuni, S. Ked Nova Faradilla, S. Ked Faculty of Medicine University of Riau Pekanbaru, Riau 2009 Files of DrsMed FK UR (http://www.files-of-drsmed.tk 0 INTTRODUCTION
More informationUterine resectoscopic myomectomy with and without microrelin pretreatment: a single-blinded randomized clinical trial.
Biomedical Research 2017; 28 (16): 6963-6967 ISSN 0970-938X www.biomedres.info Uterine resectoscopic myomectomy with and without microrelin pretreatment: a single-blinded randomized clinical trial. Abbas
More informationThe value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial
Human Reproduction, Vol.25, No.9 pp. 2264 2269, 2010 Advanced Access publication on July 27, 2010 doi:10.1093/humrep/deq188 ORIGINAL ARTICLE Gynaecology The value of pre-operative treatment with GnRH analogues
More informationJSLS. Combining Myoma Coagulation with Endometrial Ablation/Resection Reduces Subsequent Surgery Rates. Herbert A. Goldfarb, MD ABSTRACT INTRODUCTION
JSLS Combining Myoma Coagulation with Endometrial Ablation/Resection Reduces Subsequent Surgery Rates Herbert A. Goldfarb, MD ABSTRACT Background: This study compares results of endometrial ablation alone
More informationUterine-Sparing Treatment Options for Symptomatic Uterine Fibroids
Uterine-Sparing Treatment Options for Symptomatic Uterine Fibroids Developed in collaboration Learning Objective Upon completion, participants should be able to: Review uterine-sparing fibroid therapies
More informationInternational Journal of Scientific Research and Reviews
Research article Available online www.ijsrr.org ISSN: 2279 0543 International Journal of Scientific Research and Reviews Efficacy of Ulipristal Acetate In Management of Symptomatic Uterine Fibroids : A
More informationThe Use of GnRH Agonists in the Treatment of Endometriomas With or Without Drainage
The Use of GnRH Agonists in the Treatment of Endometriomas With or Without Drainage Pages with reference to book, From 30 To 32 Sertac Batioglu, Havva Celikkanat, Mustafa Ugur, Leyla Mollamahmutoglu, Huseyin
More informationSubject Index. Cavaterm, endometrial ablation complications 146, 150 contraindications 152 cost analysis compared with hysterectomy
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOO Subject Index Abnormal uterine bleeding, see also Adenomyosis, Endometrial cancer, Menorrhagia dilatation and curettage 21, 22, 25 hysteroscopy of premenopausal women anesthesia
More informationEVALUATING THE INFERTILE PATIENT-COUPLES. Stephen Thorn, MD
EVALUATING THE INFERTILE PATIENT-COUPLES Stephen Thorn, MD Overview The field of reproductive medicine continues to evolve rapidly by offering newer diagnostic testing and therapeutic options to improve
More informationLaparoscopy and Hysteroscopy
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Laparoscopy and Hysteroscopy A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of
More informationLaparoscopic myomectomy for infertile patients with intramural fibroids: A retrospective study at a tertiary endoscopic centre
ORIGINAL ARTICLE Laparoscopic myomectomy for infertile patients with intramural fibroids: A retrospective study at a tertiary endoscopic centre R J Lourens, MB ChB T I Siebert, MMed (O&G), PhD T F Kruger,
More informationCY Tse, AMK Chow, SCS Chan. Introduction
Effects of an extended-interval dosing regimen of triptorelin depot on the hormonal profile of patients with endometriosis: prospective observational study CY Tse, AMK Chow, SCS Chan Objective. To evaluate
More informationSTUDY ON THE CHANGES IN SEXUAL FUNCTIONING AND CLINICAL SYMPTOMS BEFORE AND AFTER RADIOFREQUENCY MYOLYSIS IN WOMEN WITH UTERINE MYOMA
ORIGINAL ARTICLE Korean J Obstet Gynecol 2011;54(9):529-535 http://dx.doi.org/10.5468/kjog.2011.54.9.529 pissn 2233-5188 eissn 2233-5196 STUDY ON THE CHANGES IN SEXUAL FUNCTIONING AND CLINICAL SYMPTOMS
More informationEndometriosis and Infertility - FAQs
Published on: 8 Apr 2013 Endometriosis and Infertility - FAQs Introduction The inner lining of the uterus is called the endometrium and it responds to changes that take place during a woman's monthly menstrual
More informationCLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION
Donald L. Renfrew, MD Radiology Associates of the Fox Valley, 333 N. Commercial Street, Suite 100, Neenah, WI 54956 2/12/2011 Radiology Quiz of the Week # 7 Page 1 CLINICAL PRESENTATION AND RADIOLOGY QUIZ
More informationUnusual complication after uterine artery embolization and laparoscopic myomectomy in a woman wishing to preserve future fertility
CASE REPORT Unusual complication after uterine artery embolization and laparoscopic myomectomy in a woman wishing to preserve future fertility Olivier Donnez, M.D., Pascale Jadoul, M.D., Jean Squifflet,
More informationInvestigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle?
Investigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle? Introduction: The menstrual cycle (changes within the uterus) is an approximately 28-day cycle that
More informationMedical treatment for uterine fibroids
Medical treatment for uterine fibroids Prof Mary Ann Lumsden Prof of Gynaecology and Medical Education University of Glasgow Senior Vice President RCOG Conflict of Interest Chair, Guideline development
More information5/5/2010. Infertility FINANCIAL DISCLOSURE. Infertility Definition. Objectives. Normal Human Fertility. Normal Menstrual Cycle
Infertility FINANCIAL DISCLOSURE I HAVE NO FINANCIAL INTEREST IN ANY OF THE PRODUCTS MENTIONED IN MY PRESENTATION Bryan K. Rone, M.D. University of Kentucky Obstetrics and Gynecology I AM RECEIVING COMPENSATION
More informationDipartimento Materno-Infantile Direttore : Paolo Puggina. Miomectomia laparoscopica indicazioni e limiti Giuseppe De Francesco
Dipartimento Materno-Infantile Direttore : Paolo Puggina Miomectomia laparoscopica indicazioni e limiti Giuseppe De Francesco The clinical dilemma is whether we treat all symptomatic uterine leiomyomas
More informationHormonal Control of Human Reproduction
Hormonal Control of Human Reproduction Bởi: OpenStaxCollege The human male and female reproductive cycles are controlled by the interaction of hormones from the hypothalamus and anterior pituitary with
More informationEndometrial line thickness in different conditions.
Endometrial line thickness in different conditions 1 Endometrial thickens in response to Rising estrogen levels during the menstrual cycle and then shedding endometrial at the times of menses 2 The thickens
More informationInfertility DR. RAHUL BEVARA
Infertility DR. RAHUL BEVARA Definitions Infertility is defined as the inability to conceive after one year of unprotected coitus. Affects 10-15% of couples Primary Infertility, that is inability to conceive
More informationEndometriosis. What you need to know. 139 Dumaresq Street Campbelltown Phone Fax
Endometriosis What you need to know 139 Dumaresq Street Campbelltown Phone 4628 5292 Fax 4628 0349 www.nureva.com.au September 2015 What is Endometriosis? Endometriosis is a condition whereby the lining
More informationTreatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy*
Gynecology-endocrinology FERTILITY AND STERILITY Copyright 1994 The American Fertility Society Printed on acid-free paper in U S. A. Treatment of hirsutism with a gonadotropin-releasing hormone agonist
More informationEndometriosis. *Chocolate cyst in the ovary
Endometriosis What is endometriosis? Endometriosis is a common condition in young women. It's chronic, painful, and it often progressively gets worse over the time. *Chocolate cyst in the ovary Normally,
More informationCASE 41. What is the pathophysiologic cause of her amenorrhea? Which cells in the ovary secrete estrogen?
CASE 41 A 19-year-old woman presents to her gynecologist with complaints of not having had a period for 6 months. She reports having normal periods since menarche at age 12. She denies sexual activity,
More informationVirtaMed GynoS hysteroscopy Module descriptions
VirtaMed GynoS hysteroscopy Module descriptions VirtaMed AG Rütistr. 12, 8952 Zurich Switzerland info@virtamed.com www.virtamed.com Phone: +41 44 500 9690 Table of contents Table of contents... 1 Essential
More informationCOLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS, SINGAPORE 2006
COLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS, SINGAPORE 2006 CONSENSUS STATEMENT ON THE MANAGEMENT AND EVALUATION OF MENORRHAGIA (INCLUDING MANAGEMENT OF FIBROIDS) Introduction Menorrhagia is defined as
More informationReproduction and Development. Female Reproductive System
Reproduction and Development Female Reproductive System Outcomes 5. Identify the structures in the human female reproductive system and describe their functions. Ovaries, Fallopian tubes, Uterus, Endometrium,
More informationAssessment of uterine cavity by hysteroscopy in assisted reproduction programme and its influence on pregnancy outcome
Arch Gynecol Obstet (2006) 274:160 164 DOI 10.1007/s00404-006-0174-7 ORIGINAL ARTICLE Assessment of uterine cavity by hysteroscopy in assisted reproduction programme and its influence on pregnancy outcome
More informationPreoperative Evaluation of Submucosal Myoma by Virtual Hysteroscopy
Virtual Hysteroscopy Takeda et al Preoperative Evaluation of Submucosal Myoma by Virtual Hysteroscopy Akihiro Takeda, M.D., Shuichi Manabe, M.D., Satoyo Hosono, M.D., and Hiromi Nakamura, M.D. Abstract
More informationFreedom of Information
ND ref. FOI/16/309 Freedom of Information Thank you for your 19/10/16 request for the following information: Under the Freedom of Information Act, please could you fill out the following Freedom of Information
More informationHysteroscopic Endometrial Destruction, Optimum Method for Preoperative Endometrial Preparation: A Prospective, Randomized, Multicenter Evaluation
SCIENTIFIC PAPER Hysteroscopic Endometrial Destruction, Optimum Method for Preoperative Endometrial Preparation: A Prospective, Randomized, Multicenter Evaluation O. Shawki, MD, A. Peters, DO, S. Abraham-Hebert,
More information10.7 The Reproductive Hormones
10.7 The Reproductive Hormones December 10, 2013. Website survey?? QUESTION: Who is more complicated: men or women? The Female Reproductive System ovaries: produce gametes (eggs) produce estrogen (steroid
More informationHysteroscopic polypectomy in 240 premenopausal and postmenopausal women
Hysteroscopic polypectomy in 240 premenopausal and postmenopausal women Sangchai Preutthipan, M.D., and Yongyoth Herabutya, F.R.C.O.G. Department of Obstetrics and Gynaecology, Faculty of Medicine, Ramathibodi
More informationStage 4 - Ovarian Cancer Symptoms
WELCOME Stage 4 - Ovarian Cancer Symptoms University of Baghdad College of Nursing Department of Basic Medical Sciences Overview of Anatomy and Physioloy II Second Year Students Asaad Ismail Ahmad,
More informationENDOMETRIOSIS. Bladder endometriosis must be considered as bladder adenomyosis MATERIALS AND METHODS
FERTILITY AND STERILITY VOL. 74, NO. 6, DECEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. ENDOMETRIOSIS Bladder
More informationAssessment of uterine cavity after hystroscopic removal of sub- mucous fibroids by morcellation
The Egyptian Journal of Hospital Medicine (October 2018) Vol. 73 (11), Page 7982-7987 Assessment of uterine cavity after hystroscopic removal of sub- mucous fibroids by morcellation Waleed A. Ayad Department
More informationImproved Fertility Following Enucleation of Intramural Myomas in Infertile Women
Original Article Improved Fertility Following Enucleation of Intramural Myomas in Infertile Women Yu Cui Tian 1, Jian Hong Wu 2, Hong Mei Wang 1, Yin Mei Dai 3 1 Department of Perinatal Medicine, Beijing
More informationKey Words: Endometriosis, GnRH-a, goserelin, Zoladex, estrogen, sex-steroid add-back therapy,
FERTLTY AND STERLTY Copyright 1995 American Society for Reproductive Medicine Vol. 64, No. 5, November 1995 Printed on acid free paper in U. S. A. Comparison of the gonadotropin-releasing hormone agonist
More informationUterine Fibroid on Women's Fertility and Pregnancy Outcome in Delta State, Nigeria
Uterine Fibroid on Women's Fertility and Pregnancy Outcome in Delta State, Nigeria Osuji, G.A Obubu, M.* Obiora-Ilouno H.O Department of Statistics, Nnamdi Azikiwe University, Awka, Nigeria Abstract The
More informationHormonal Treatment and Pelviscopic Myomectomy
Diagnostic and Therapeutic Endoscopy, 1995, Vol. 1, pp. 217-221 Reprints available directly from the publisher Photocopying permitted by license only (C) 1995 Harwood Academic Publishers GmbH Printed in
More informationWeb Activity: Simulation Structures of the Female Reproductive System
differentiate. The epididymis is a coiled tube found along the outer edge of the testis where the sperm mature. 3. Testosterone is a male sex hormone produced in the interstitial cells of the testes. It
More informationUlipristal acetate (UPA) for fibroids IVF outcomes following treatment with UPA after IVF failure: series of 2 case reports
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Kale AR. Int J Reprod Contracept Obstet Gynecol. 2017 Jul;6(7):3177-3181 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20172959
More informationD-Trp-6-luteinizing hormone-releasing hormone microcapsules in the treatment of uterine leiomyomas
FERTILITY AND STERILITY Copyright" '1989 The American Fertility Society Vol. 52, No.3, Septemher 1989 Printed on acid-free paper in U.S.A. D-Trp-6-luteinizing hormone-releasing hormone microcapsules in
More informationENDOMETRIAL RESECTION FOR THE TREATMENT OF MENORRHAGIA ENDOMETRIAL RESECTION FOR THE TREATMENT OF MENORRHAGIA. Study Patients
ENDOMETRIAL RESECTION FOR THE TREATMENT OF MENORRHAGIA ENDOMETRIAL RESECTION FOR THE TREATMENT OF MENORRHAGIA HUGH O CONNOR, M.R.C.O.G., AND ADAM MAGOS, M.D. ABSTRACT Background Endometrial resection is
More informationAkihiro Takeda, MD, Masahiko Mori, MD, Kotaro Sakai, MD, Takashi Mitsui, MD, and Hiromi Nakamura, MD
Journal of Minimally Invasive Gynecology (2007) 14, 770 775 Parasitic peritoneal leiomyomatosis diagnosed 6 years after laparoscopic myomectomy with electric tissue morcellation: Report of a case and review
More informationIs the endometriosis recurrence rate increased after ovarian hyperstimulation?
Is the endometriosis recurrence rate increased after ovarian hyperstimulation? Thomas M. D Hooghe, M.D., Ph.D., Bénédicte Denys, M.D., Carl Spiessens, Ph.D., Christel Meuleman, M.D., and Sophie Debrock,
More informationPALM-COEIN: Your AUB Counseling Guide
PALM-COEIN: Your AUB Counseling Guide 10 million+ Treat the cause, not the symptom In the U.S, more than 10 million women between the ages of 35 and 49 are affected by AUB 1 Diagnosis Cause Structural
More informationHistologic study of peritoneal endometriosis in infertile women
FERTILITY AND STERILITY Copyright" 1990 The American Fertility Society Printed on acid-free paper in U.S.A. Histologic study of peritoneal endometriosis in infertile women Michelle Nisolle, M.D. Benedicte
More informationFemale Reproductive System. Lesson 10
Female Reproductive System Lesson 10 Learning Goals 1. What are the five hormones involved in the female reproductive system? 2. Understand the four phases of the menstrual cycle. Human Reproductive System
More informationClinical Efficacy and Complications of Uterine Artery Embolization in Symptomatic Uterine Fibroids
Global Journal of Health Science; Vol. 8, No. 7; 2016 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Clinical Efficacy and Complications of Uterine Artery Embolization
More informationPREGNANCY OUTCOMES AFTER MYOMECTOMY IN INFERTILE WOMEN WITH FIBROIDS: A SYSTEMATIC REVIEW OF THE LITERATURE A THESIS SUBMITTED TO THE FACULTY OF THE
PREGNANCY OUTCOMES AFTER MYOMECTOMY IN INFERTILE WOMEN WITH FIBROIDS: A SYSTEMATIC REVIEW OF THE LITERATURE A THESIS SUBMITTED TO THE FACULTY OF THE UNIVERSITY OF MINNESOTA BY ESTHER CHINWEUCHE OKEKE IN
More informationLaparoscopic myomectomy for symptomatic uterine myomas
MODERN TRENDS Edward E. Wallach, M.D. Associate Editor Laparoscopic myomectomy for symptomatic uterine myomas Bradley S. Hurst, M.D., Michelle L. Matthews, M.D., and Paul B. Marshburn, M.D. Division of
More informationINFERTILITY CAUSES. Basic evaluation of the female
INFERTILITY Infertility is the inability to conceive after 12 months of unprotected intercourse. There are multiple causes of infertility and a systematic way to evaluate the condition. Let s look at some
More informationGynecologic Decision Making Based on Sonographic Findings
Gynecologic Decision Making Based on Sonographic Findings Mindy Goldman, MD Department of Obstetrics & Gynecology & Vickie A. Feldstein, MD Department of Radiology University of California, San Francisco
More informationLaparoscopy and Endometriosis: Preventing Complications and Improving Outcomes. Luis C. Paez M.D.
Laparoscopy and Endometriosis: Preventing Complications and Improving Outcomes Luis C. Paez M.D. Assumptions Pelvic pain Not desiring immediate fertility H & P suggest endometriosis OC/NSAID failures Endo
More informationContents: Benign Diseases of the Uterus
COLLEGE OF MEDICINE DEPT. OF OBSTETRICS AND GYNECOLOGY Benign Diseases of the Uterus Dr.Ayman Hussien Shaamash MBBCH, MSc., MD. (Egypt) Professor of OB./Gyn. Faculty of Medicine. King khalid University
More informationMedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.018.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2017
MedStar Health, Inc. POLICY AND PROCEDURE MANUAL PA.018.MH Infertility- Treatment This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP (Not Covered) MedStar
More informationDiagnostic Features and Therapeutic Consequences of Hysteroscopy in Women with Abnormal Uterine Bleeding and Abortion
American Journal of Applied Sciences 9 (1): 13-17, 2012 ISSN 1546-9239 2012 Science Publications Diagnostic Features and Therapeutic Consequences of Hysteroscopy in Women with Abnormal Uterine Bleeding
More informationEssure By Mayo Clinic staff
Page 1 of 5 Reprints A single copy of this article may be reprinted for personal, noncommercial use only. Essure By Mayo Clinic staff Original Article: http://www.mayoclinic.com/health/essure/my00999 Definition
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation in uterine leiomyoma management, 719 723 Adnexal masses diagnosis of, 664 667 imaging in, 664 665 laboratory studies in, 665
More informationEgg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer
FERTILITY AND STERILITY Copyright tl 1989 The American Fertility Society Printed on acid-free paper in U. S.A. Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization
More informationUTERINE LEIOMYOSARCOMA. About Uterine leiomyosarcoma
UTERINE LEIOMYOSARCOMA Uterine Lms, Ulms Or Just Lms Rare uterine malignant tumour that arises from the smooth muscular part of the uterine wall. Diagnosis Female About Uterine leiomyosarcoma Uterine LMS
More informationEndometrial Ablation. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Endometrial Ablation Page: 1 of 10 Last Review Status/Date: December 2012 Endometrial Ablation
More informationI. ART PROCEDURES. A. In Vitro Fertilization (IVF)
DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment
More informationEndometrial Cancer Biopsy of the endometrium Evaluation of women of all ages
Endometrial Cancer Biopsy of the endometrium Evaluation of women of all ages Barbara S. Apgar, MD, MS Professor of Family Medicine University of Michigan Health System Ann Arbor, Michigan Cancer of the
More informationTissue Morcellation: Managing Risks to Drive Best Patient Outcomes
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationLong-term Results in the Treatment of Menorrhagia and Hypermenorrhea With a Thermal Balloon Endometrial Ablation Technique
Longterm Results in the Treatment of Menorrhagia and Hypermenorrhea With a Thermal Balloon Endometrial Ablation Technique L. Mettler, Prof Dr Med SCIENTIFIC PAPER ABSTRACT Background and Objectives: Evaluation
More informationMEDICAL POLICY SUBJECT: ENDOMETRIAL ABLATION
MEDICAL POLICY PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationManagement of Abnormal Uterine Bleeding. Julie Strickland MD, MPH University of Missouri Kansas City Department of Obstetrics and Gynecology
Management of Abnormal Uterine Bleeding Julie Strickland MD, MPH University of Missouri Kansas City Department of Obstetrics and Gynecology AUB Abnormal uterine bleeding (AUB): fairly broad term referring
More informationManaging infertility when adenomyosis and endometriosis co-exist
Managing infertility when adenomyosis and endometriosis co-exist Jinhua Leng Beijing,China Endometriosis Endometriosis (EM) is a common, benign, ovary hormone-dependent gynecologic disorder which affects
More informationIn Vitro Fertilization What to expect
Patient Education In Vitro Fertilization What to expect This handout describes how to prepare for and what to expect when you have in vitro fertilization. It provides written information about this process,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abdominal myomectomy in leiomyoma management, 77 Abnormal uterine bleeding (AUB) described, 103 105 normal menstrual bleeding vs., 104
More informationARTICLE IN PRESS. Tarek Shokeir, M.D., Muhammed El-Shafei, M.D., Hamed Yousef, M.D., Abdel-Fattah Allam, M.D., and Ehab Sadek, M.D.
Submucous myomas and their implications in the pregnancy rates of patients with otherwise unexplained primary infertility undergoing hysteroscopic myomectomy: a randomized matched control study Tarek Shokeir,
More informationCNGOF Guidelines for the Management of Endometriosis
CNGOF Guidelines for the Management of Endometriosis Anatomoclinical forms of endometriosis Definitions Endometriosis is defined as the presence of endometrial tissue containing both glands and stroma
More informationRETRACTED. Tarek Shokeir, M.D., Muhammed El-Shafei, M.D., Hamed Yousef, M.D., Abdel-Fattah Allam, M.D., and Ehab Sadek, M.D.
Submucous myomas and their implications in the pregnancy rates of patients with otherwise unexplained primary infertility undergoing hysteroscopic myomectomy: a randomized matched control study Tarek Shokeir,
More informationUterine fibroid shrinkage after short-term use of selective progesterone receptor modulator or gonadotropin-releasing hormone agonist
Original Article Obstet Gynecol Sci 2017;60(1):69-73 https://doi.org/10.5468/ogs.2017.60.1.69 pissn 2287-8572 eissn 2287-8580 Uterine fibroid shrinkage after short-term use of selective progesterone receptor
More informationRole of diagnostic hysteroscopy in evaluation of abnormal uterine bleeding and its histopathological correlation
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Chaudhari KR et al. Int J Reprod Contracept Obstet Gynecol. 2014 Sep;3(3):666-670 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationPhases of the Ovarian Cycle
OVARIAN CYCLE An ovary contains many follicles, and each one contains an immature egg called an oocyte. A female is born with as many as 2 million follicles, but the number is reduced to 300,000 to 400,000
More informationMeet the Authors: Fertility Outcomes After Hysteroscopic Morcellation of Polyps and Fibroids with the MyoSure System
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-industry-feature/meet-authors-fertility-outcomes-afterhysteroscopic-morcellation-polyps-and-fibroids-myosure-system/9511/
More informationNot all roads point to hysterectomy: treatment options for fibroids
Not all roads point to hysterectomy: treatment options for fibroids MAUREEN KOHI, MD DEPARTMENT OF RADIOLOGY JEANNETTE LAGER, MD DEPARTMENT OF OBSTETRICS, GYNECOLOGY AND REPRODUCTIVE SCIENCES A lady, recently
More informationInternational Federation of Fertility Societies. Global Standards of Infertility Care
International Federation of Fertility Societies Global Standards of Infertility Care Standard 10 Management of leiomyoma (fibroids) in a patient presenting with infertility Name Version number Author Date
More informationAssisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi
Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various
More informationEvaluation of the Infertile Couple
Overview and Definition Infertility is defined as the inability of a couple to fall pregnant after one year of unprotected intercourse. Infertility is a very common condition as in any given year about
More informationInvestigating HMB- an evidence based approach
BSGE Meeting: Contemporary management of heavy menstrual bleeding (HMB) in primary and secondary care: (7 th December 2018, RCOG) Investigating HMB- an evidence based approach T. Justin Clark MB ChB, MD(Hons),
More informationInfertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary
Subfertility Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Infertility affects about 15 % of couples. age of the female. Other factors that
More information5 Mousa Al-Abbadi. Ola Al-juneidi & Obada Zalat. Ahmad Al-Tarefe
5 Mousa Al-Abbadi Ola Al-juneidi & Obada Zalat Ahmad Al-Tarefe Abnormal Uterine Bleeding (AUB) AUB is a very common scenario or symptom where women complain of menorrhagia (heavy and/or for long periods),
More information